Opendata, web and dolomites

EAVI2020 SIGNED

European AIDS Vaccine Initiative 2020

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EAVI2020 project word cloud

Explore the words cloud of the EAVI2020 project. It provides you a very rough idea of what is the project "EAVI2020" about.

em    continues    small    viral    prediction    protective    eliminate    heterologous    placed    discovery    designed    immunization    overcome    candidates    course    expertise    iterative    highest    ultimately    pool    rate    biotechs    genetics    infection    emphasis    collaborators    strategies    host    modalities    eradication    therapeutic    global    disease    clinical    progression    mitigate    people    despite    diverse    adjuvants    prime    hiv    international    chance    countries    clinic    gt    platform    human    competitive    vectors    complement    curve    technologies    forces    impacting    innovative    australian    refine    public    responsible    rapid    reduce    groups    acknowledged    infections    animal    million    immunogens    boost    vaccine    protecting    experimental    aids    spread    agreed    eavi2020    medicine    pandemic    shift    risk    stage    canadian    35    schedules    join    select    bottleneck    homologous    gender    eavi    models    preventive   

Project "EAVI2020" data sheet

The following table provides information about the project.

Coordinator
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE 

Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ
website: http://www.imperial.ac.uk/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.eavi2020.eu/
 Total cost 24˙088˙765 €
 EC max contribution 22˙948˙022 € (95%)
 Programme 1. H2020-EU.3.1.2. (Preventing disease)
 Code Call H2020-PHC-2015-single-stage_RTD
 Funding Scheme RIA
 Starting year 2015
 Duration (year-month-day) from 2015-11-01   to  2020-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE UK (LONDON) coordinator 6˙118˙355.00
2    POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH AT (KLOSTERNEUBURG) participant 3˙449˙000.00
3    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) participant 2˙300˙415.00
4    FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA ES (BARCELONA) participant 1˙998˙031.00
5    COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES FR (PARIS 15) participant 1˙390˙635.00
6    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) participant 1˙140˙062.00
7    KAROLINSKA INSTITUTET SE (STOCKHOLM) participant 895˙561.00
8    OSPEDALE SAN RAFFAELE SRL IT (MILANO) participant 669˙938.00
9    FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA ES (BARCELONA) participant 633˙185.00
10    INTERNATIONAL AIDS VACCINE INITIATIVE INC US (NEW YORK) participant 626˙000.00
11    UNIVERSITE GRENOBLE ALPES FR (SAINT MARTIN D'HERES) participant 612˙907.00
12    ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM NL (AMSTERDAM) participant 571˙500.00
13    UNIVERSITATSKLINIKUM ERLANGEN DE (ERLANGEN) participant 564˙021.00
14    INSTITUTO DE SALUD CARLOS III ES (MADRID) participant 403˙828.00
15    ISTITUTO SUPERIORE DI SANITA IT (ROMA) participant 389˙700.00
16    BIONTECH RNA PHARMACEUTICALS GMBH DE (MAINZ) participant 371˙375.00
17    NEMZETI ELELMISZERLANC-BIZTONSAGI HIVATAL HU (BUDAPEST) participant 211˙298.00
18    UNIVERSITY OF SOUTHAMPTON UK (SOUTHAMPTON) participant 210˙343.00
19    LUDWIG BOLTZMANN GESELLSCHAFT GMBH AT (WIEN) participant 201˙250.00
20    KING'S COLLEGE LONDON UK (LONDON) participant 190˙612.00
21    GENOME RESEARCH LIMITED UK (LONDON) participant 0.00
22    STICHTING INTERNATIONAL AIDS VACCINE INITIATIVE THE NETHERLANDS NL (AMSTERDAM) participant 0.00
23    THE UNIVERSITY OF WESTERN ONTARIO CA (ONTARIO -LONDON) participant 0.00
24    UNIVERSITE JOSEPH FOURIER GRENOBLE 1 FR (GRENOBLE) participant 0.00
25    UNIVERSITY OF MELBOURNE AU (MELBOURNE) participant 0.00
26    UNIVERSITY OF NEW SOUTH WALES AU (SYDNEY) participant 0.00

Map

 Project objective

HIV-1 is responsible for a global pandemic of 35 million people, and continues to spread at a rate of >2 million new infections/year. It is widely acknowledged that a protective vaccine would be the most effective means to reduce HIV-1 spread and ultimately eliminate the pandemic, while a therapeutic vaccine may help mitigate the clinical course of disease and lead to strategies of viral eradication. However despite 30 years of research, we do not have a vaccine capable of protecting from HIV-1 infection or impacting on disease progression. This in part represents the challenge of identifying immunogens and vaccine modalities with reduced risk of failure in late stage development. To overcome this bottleneck some of the most competitive research groups in vaccine discovery from European public institutions and biotechs from 9 EU countries together with top Australian and Canadian groups and US collaborators, have agreed to join forces in EAVI, providing a pool of international expertise at the highest level. EAVI2020 will provide a platform for the discovery and selection of several new, diverse and novel preventive and/or therapeutic vaccine candidates for HIV/AIDS. Emphasis will be placed on early rapid, iterative, small Experimental medicine (EM) human vaccine studies to select and refine the best immunogens, adjuvants, vectors, homologous and heterologous prime–boost schedules, and determine the impact of host factors such as gender and genetics. Animal models will be used to complement human studies, and to select novel immunization technologies to be advanced to the clinic. To shift the “risk curve” in product development we will develop innovative risk prediction methods, specifically designed to reduce the risk associated with late stage preventive or therapeutic vaccine failure, increasing the chance of discovery of an effective vaccine.

 Deliverables

List of deliverables.
EAVI2020 Website Websites, patent fillings, videos etc. 2019-09-04 11:55:06
Marketing and Dissemination Kit Other 2019-09-04 11:55:06

Take a look to the deliverables list in detail:  detailed list of EAVI2020 deliverables.

 Publications

year authors and title journal last update
List of publications.
2019 Vincent Vieillard, Béhazine Combadière, Roland Tubiana, Odile Launay, Gilles Pialoux, Laurent Cotte, Pierre-Marie Girard, Anne Simon, Yasmine Dudoit, Jacques Reynes, Jürgen Rockstroh, Felipe Garcia, Jose Gatell, Alain Devidas, Yazdan Yazdanpanah, Laurence Weiss, Gerd Fätkenheuer, Brigitte Autran, Delphine Joyeux, Shahin Gharakhanian, Patrice Debré, Christine Katlama
HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial
published pages: , ISSN: 2059-0105, DOI: 10.1038/s41541-019-0117-5
npj Vaccines 4/1 2020-01-27
2018 Carolina Beltran-Pavez, Carolina B. Ferreira, Alberto Merino-Mansilla, Amanda Fabra-Garcia, Maria Casadella, Marc Noguera-Julian, Roger Paredes, Alex Olvera, Isabel Haro, Christian Brander, Felipe Garcia, Jose M. Gatell, Eloisa Yuste, Victor Sanchez-Merino
Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant
published pages: e0208345, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0208345
PLOS ONE 13/12 2020-01-27
2019 Gemma E. Seabright, Katie J. Doores, Dennis R. Burton, Max Crispin
Protein and Glycan Mimicry in HIV Vaccine Design
published pages: 2223-2247, ISSN: 0022-2836, DOI: 10.1016/j.jmb.2019.04.016
Journal of Molecular Biology 431/12 2020-01-27
2019 Esther Broset, Narcís Saubi, Núria Guitart, Nacho Aguilo, Santiago Uranga, Athina Kilpeläinen, Yoshiki Eto, Tomáš Hanke, Jesús Gonzalo-Asensio, Carlos Martín, Joan Joseph-Munné
MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
published pages: 253-264, ISSN: 2329-0501, DOI: 10.1016/j.omtm.2019.01.014
Molecular Therapy - Methods & Clinical Development 13 2020-01-27
2019 Marta Ruiz-Riol, Christian Brander
Can we just kick-and-kill HIV: possible challenges posed by the epigenetically controlled interplay between HIV and host immunity
published pages: 931-935, ISSN: 1750-743X, DOI: 10.2217/imt-2019-0092
Immunotherapy 11/11 2020-01-27
2019 Meng Yuan, Christopher A. Cottrell, Gabriel Ozorowski, Marit J. van Gils, Sonu Kumar, Nicholas C. Wu, Anita Sarkar, Jonathan L. Torres, Natalia de Val, Jeffrey Copps, John P. Moore, Rogier W. Sanders, Andrew B. Ward, Ian A. Wilson
Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing Antibodies
published pages: 873-883.e5, ISSN: 1931-3128, DOI: 10.1016/j.chom.2019.04.011
Cell Host & Microbe 25/6 2020-01-27
2019 Combadière, Beaujean, Chaudesaigues, Vieillard
Peptide-Based Vaccination for Antibody Responses Against HIV
published pages: 105, ISSN: 2076-393X, DOI: 10.3390/vaccines7030105
Vaccines 7/3 2020-01-27
2019 Néstor Vázquez Bernat, Martin Corcoran, Uta Hardt, Mateusz Kaduk, Ganesh E. Phad, Marcel Martin, Gunilla B. Karlsson Hedestam
High-Quality Library Preparation for NGS-Based Immunoglobulin Germline Gene Inference and Repertoire Expression Analysis
published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2019.00660
Frontiers in Immunology 10 2020-01-27
2019 Mitch Brinkkemper, Kwinten Sliepen
Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies
published pages: 76, ISSN: 2076-393X, DOI: 10.3390/vaccines7030076
Vaccines 7/3 2020-01-27
2019 Dirk Eggink, Ilja Bontjer, Steven W. de Taeye, Johannes P. M. Langedijk, Ben Berkhout, Rogier W. Sanders
HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry
published pages: 5736-5746, ISSN: 0021-9258, DOI: 10.1074/jbc.RA119.007360
Journal of Biological Chemistry 294/15 2020-01-27
2019 Yasunori Watanabe, Thomas A. Bowden, Ian A. Wilson, Max Crispin
Exploitation of glycosylation in enveloped virus pathobiology
published pages: 1480-1497, ISSN: 0304-4165, DOI: 10.1016/j.bbagen.2019.05.012
Biochimica et Biophysica Acta (BBA) - General Subjects 1863/10 2020-01-27
2019 Alba Torrents de la Peña, Kimmo Rantalainen, Christopher A. Cottrell, Joel D. Allen, Marit J. van Gils, Jonathan L. Torres, Max Crispin, Rogier W. Sanders, Andrew B. Ward
Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics
published pages: e1007920, ISSN: 1553-7374, DOI: 10.1371/journal.ppat.1007920
PLOS Pathogens 15/7 2020-01-27
2019 Athina Kilpeläinen, Narcís Saubi, Núria Guitart, Nathifa Moyo, Edmund G. Wee, Krupa Ravi, Tomáš Hanke, Joan Joseph
Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice
published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2019.00923
Frontiers in Immunology 10 2020-01-27
2019 Kwinten Sliepen, Byung Woo Han, Ilja Bontjer, Petra Mooij, Fernando Garces, Anna-Janina Behrens, Kimmo Rantalainen, Sonu Kumar, Anita Sarkar, Philip J. M. Brouwer, Yuanzi Hua, Monica Tolazzi, Edith Schermer, Jonathan L. Torres, Gabriel Ozorowski, Patricia van der Woude, Alba Torrents de la Peña, Mariëlle J. van Breemen, Juan Miguel Camacho-Sánchez, Judith A. Burger, Max Medina-Ramírez, Nuria G
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence
published pages: , ISSN: 2041-1723, DOI: 10.1038/s41467-019-10262-5
Nature Communications 10/1 2020-01-27
2019 Philip J. M. Brouwer, Aleksandar Antanasijevic, Zachary Berndsen, Anila Yasmeen, Brooke Fiala, Tom P. L. Bijl, Ilja Bontjer, Jacob B. Bale, William Sheffler, Joel D. Allen, Anna Schorcht, Judith A. Burger, Miguel Camacho, Daniel Ellis, Christopher A. Cottrell, Anna-Janina Behrens, Marco Catalano, Iván del Moral-Sánchez, Thomas J. Ketas, Celia LaBranche, Marit J. van Gils, Kwinten Sliepen, Lance
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
published pages: , ISSN: 2041-1723, DOI: 10.1038/s41467-019-12080-1
Nature Communications 10/1 2020-01-27
2019 Athina Kilpeläinen, Narcís Saubi, Núria Guitart, Alex Olvera, Tomáš Hanke, Christian Brander, Joan Joseph
Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice
published pages: 78, ISSN: 2076-393X, DOI: 10.3390/vaccines7030078
Vaccines 7/3 2020-01-27
2019 Rebecca Heß, Michael Storcksdieck genannt Bonsmann, Dennis Lapuente, Andre Maaske, Carsten Kirschning, Jürgen Ruland, Bernd Lepenies, Drew Hannaman, Matthias Tenbusch, Klaus Überla
Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination
published pages: 153, ISSN: 1999-4915, DOI: 10.3390/v11020153
Viruses 11/2 2020-01-27
2019 Edmund G. Wee, Nathifa A. Moyo, Kevin O. Saunders, Celia LaBranche, Filippo Donati, Silvia Capucci, Robert Parks, Nicola Borthwick, Zara Hannoun, David C. Montefiori, Barton F. Haynes, Tomáš Hanke
Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1
published pages: 148-160, ISSN: 2329-0501, DOI: 10.1016/j.omtm.2019.06.003
Molecular Therapy - Methods & Clinical Development 14 2020-01-27
2018 Ester Lopez, Robin J. Shattock, Stephen J. Kent, Amy W. Chung
The Multifaceted Nature of Immunoglobulin A and Its Complex Role in HIV
published pages: 727-738, ISSN: 0889-2229, DOI: 10.1089/aid.2018.0099
AIDS Research and Human Retroviruses 34/9 2020-01-27
2018 Jenna Anderson, Thorunn A. Olafsdottir, Sven Kratochvil, Paul F. McKay, Malin Östensson, Josefine Persson, Robin J. Shattock, Ali M. Harandi
Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in Humans
published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2018.00301
Frontiers in Immunology 9 2019-09-04
2017 S. Stenler, K. E. Lundin, L. Hansen, S. Petkov, N. Mozafari, M. Isaguliants, P. Blomberg, C. I. E. Smith, D. M. Goldenberg, C.-H. Chang, K. Ljungberg, J. Hinkula, B. Wahren
Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses
published pages: 2849-2858, ISSN: 2164-5515, DOI: 10.1080/21645515.2017.1338546
Human Vaccines & Immunotherapeutics 13/12 2019-09-04
2018 Alex Olvera, Javier P. Martinez, Maria Casadellà, Anuska Llano, Míriam Rosás, Beatriz Mothe, Marta Ruiz-Riol, Gemma Arsequell, Gregorio Valencia, Marc Noguera-Julian, Roger Paredes, Andreas Meyerhans, Christian Brander
Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy In Vitro
published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2017.02010
Frontiers in Immunology 8 2019-09-04
2017 Sven Kratochvil, Paul F. McKay, Amy W. Chung, Stephen J. Kent, Jill Gilmour, Robin J. Shattock
Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination
published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2017.01883
Frontiers in Immunology 8 2019-09-04
2018 Yoann Aldon, Paul F. McKay, Joel Allen, Gabriel Ozorowski, Réka Felfödiné Lévai, Monica Tolazzi, Paul Rogers, Linling He, Natalia de Val, Katalin Fábián, Gabriella Scarlatti, Jiang Zhu, Andrew B. Ward, Max Crispin, Robin J. Shattock
Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope Trimers
published pages: 3324-3338.e5, ISSN: 2211-1247, DOI: 10.1016/j.celrep.2018.08.051
Cell Reports 24/12 2019-09-04
2016 Karen P. Coss, Snezana Vasiljevic, Laura K. Pritchard, Stefanie A. Krumm, Molly Glaze, Sharon Madzorera, Penny L. Moore, Max Crispin, Katie J. Doores
HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual
published pages: 11132-11144, ISSN: 0022-538X, DOI: 10.1128/JVI.01542-16
Journal of Virology 90/24 2019-09-04
2018 Nuria González, Krisha McKee, Rebecca M. Lynch, Ivelin S. Georgiev, Laura Jimenez, Eulalia Grau, Eloísa Yuste, Peter D. Kwong, John R. Mascola, José Alcamí
Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors
published pages: e0193773, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0193773
PLOS ONE 13/3 2019-09-04
2018 Max Crispin, Andrew B. Ward, Ian A. Wilson
Structure and Immune Recognition of the HIV Glycan Shield
published pages: 499-523, ISSN: 1936-122X, DOI: 10.1146/annurev-biophys-060414-034156
Annual Review of Biophysics 47/1 2019-09-04
2017 Sven Kratochvil, Paul F. McKay, Jakub T. Kopycinski, Cynthia Bishop, Peter John Hayes, Luke Muir, Christopher L. Pinder, Deniz Cizmeci, Deborah King, Yoann Aldon, Bruce D. Wines, P. Mark Hogarth, Amy W. Chung, Stephen J. Kent, Kathrin Held, Christof Geldmacher, Len Dally, Nelson S. Santos, Tom Cole, Jill Gilmour, Sarah Fidler, Robin J. Shattock
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens
published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2017.00595
Frontiers in Immunology 8 2019-09-04
2016 V. Sanchez-Merino, A. Fabra-Garcia, N. Gonzalez, D. Nicolas, A. Merino-Mansilla, C. Manzardo, J. Ambrosioni, A. Schultz, A. Meyerhans, J. R. Mascola, J. M. Gatell, J. Alcami, J. M. Miro, E. Yuste
Detection of Broadly Neutralizing Activity within the First Months of HIV-1 Infection
published pages: 5231-5245, ISSN: 0022-538X, DOI: 10.1128/JVI.00049-16
Journal of Virology 90/11 2019-09-04
2017 Vladimir Temchura, Klaus Überla
Intrastructural help
published pages: 272-277, ISSN: 1746-630X, DOI: 10.1097/COH.0000000000000358
Current Opinion in HIV and AIDS 12/3 2019-09-04
2017 Anna-Janina Behrens, Max Crispin
Structural principles controlling HIV envelope glycosylation
published pages: 125-133, ISSN: 0959-440X, DOI: 10.1016/j.sbi.2017.03.008
Current Opinion in Structural Biology 44 2019-09-04
2018 Hassan Elsayed, Ghulam Nabi, William J. McKinstry, Keith K. Khoo, Johnson Mak, Andres M. Salazar, Matthias Tenbusch, Vladimir Temchura, Klaus Überla
Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines
published pages: , ISSN: 0022-538X, DOI: 10.1128/JVI.00141-18
Journal of Virology 92/14 2019-09-04
2017 J Hinkula, S Petkov, K Ljungberg, D Hallengärd, A Bråve, M Isaguliants, T Falkeborn, S Sharma, V Liakina, M Robb, M Eller, B Moss, G Biberfeld, E Sandström, C Nilsson, K Markland, P Blomberg, B Wahren
HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV
published pages: e00339, ISSN: 2405-8440, DOI: 10.1016/j.heliyon.2017.e00339
Heliyon 3/6 2019-09-04
2017 Anna-Janina Behrens, Weston B Struwe, Max Crispin
Glycosylation profiling to evaluate glycoprotein immunogens against HIV-1
published pages: 881-890, ISSN: 1478-9450, DOI: 10.1080/14789450.2017.1376658
Expert Review of Proteomics 14/10 2019-09-04
2019 Nathifa Moyo, Annette B. Vogel, Søren Buus, Stephanie Erbar, Edmund G. Wee, Ugur Sahin, Tomáš Hanke
Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA
published pages: 32-46, ISSN: 2329-0501, DOI: 10.1016/j.omtm.2018.10.010
Molecular Therapy - Methods & Clinical Development 12 2019-09-04
2017 Christopher L. Pinder, Sven Kratochvil, Deniz Cizmeci, Luke Muir, Yanping Guo, Robin J. Shattock, Paul F. McKay
Isolation and Characterization of Antigen-Specific Plasmablasts Using a Novel Flow Cytometry–Based Ig Capture Assay
published pages: 4180-4188, ISSN: 0022-1767, DOI: 10.4049/jimmunol.1701253
The Journal of Immunology 199/12 2019-09-04
2018 Hannah Mary Cheeseman, Suzanne Day, Leon Robert McFarlane, Sue Fleck, Aleisha Miller, Tom Cole, Nelson Sousa-Santos, Alethea Cope, Deniz Cizmeci, Monica Tolazzi, Edith Hwekwete, Drew Hannaman, Sven Kratochvil, Paul Francis McKay, Amy W. Chung, Stephen J. Kent, Adrian Cook, Gabriella Scarlatti, Sonya Abraham, Behazine Combadiere, Sheena McCormack, David John Lewis, Robin John Shattock
Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine
published pages: 1011-1028, ISSN: 1043-0342, DOI: 10.1089/hum.2018.075
Human Gene Therapy 29/9 2019-09-04
2017 Edmund G. Wee, Beatrice Ondondo, Peter Berglund, Jacob Archer, Andrew J. McMichael, David Baltimore, Jan H. ter Meulen, Tomáš Hanke
HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells
published pages: 494-503, ISSN: 1525-0016, DOI: 10.1016/j.ymthe.2016.12.004
Molecular Therapy 25/2 2019-09-04
2017 Olivier Lucar, Bin Su, Valérie Potard, Assia Samri, Brigitte Autran, Christiane Moog, Patrice Debré, Vincent Vieillard
Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status
published pages: 122-132, ISSN: 2352-3964, DOI: 10.1016/j.ebiom.2017.07.007
EBioMedicine 22 2019-09-04
2018 Torben Schiffner, Jesper Pallesen, Rebecca A. Russell, Jonathan Dodd, Natalia de Val, Celia C. LaBranche, David Montefiori, Georgia D. Tomaras, Xiaoying Shen, Scarlett L. Harris, Amin E. Moghaddam, Oleksandr Kalyuzhniy, Rogier W. Sanders, Laura E. McCoy, John P. Moore, Andrew B. Ward, Quentin J. Sattentau
Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins
published pages: e1006986, ISSN: 1553-7374, DOI: 10.1371/journal.ppat.1006986
PLOS Pathogens 14/5 2019-09-04
2017 Silvia Capucci, Edmund G. Wee, Torben Schiffner, Celia C. LaBranche, Nicola Borthwick, Albert Cupo, Jonathan Dodd, Hansi Dean, Quentin Sattentau, David Montefiori, Per J. Klasse, Rogier W. Sanders, John P. Moore, Tomáš Hanke
HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
published pages: e0181886, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0181886
PLOS ONE 12/8 2019-09-04
2017 Aakash Mahant, Narcís Saubi, Yoshiki Eto, Núria Guitart, Josep M ª Gatell, Tomáš Hanke, Joan Joseph
Preclinical Development of BCG.HIVA 2auxo.int , Harboring an Integrative Expression Vector, for a HIV-TB Pediatric vaccine. Enhancement of Stability and Specific HIV-1 T-cell Immunity
published pages: 00-00, ISSN: 2164-5515, DOI: 10.1080/21645515.2017.1316911
Human Vaccines & Immunotherapeutics 2019-09-04
2017 Max Medina-Ramírez, Rogier W. Sanders, Quentin J. Sattentau
Stabilized HIV-1 envelope glycoprotein trimers for vaccine use
published pages: 241-249, ISSN: 1746-630X, DOI: 10.1097/COH.0000000000000363
Current Opinion in HIV and AIDS 12/3 2019-09-04
2017 Martina Soldemo, Gunilla B. Karlsson Hedestam
Env-Specific Antibodies in Chronic Infection versus in Vaccination
published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2017.01057
Frontiers in Immunology 8 2019-09-04
2017 Rogier W. Sanders, John P. Moore
Native-like Env trimers as a platform for HIV-1 vaccine design
published pages: 161-182, ISSN: 0105-2896, DOI: 10.1111/imr.12481
Immunological Reviews 275/1 2019-09-04
2017 M. Ruiz-Riol, D. Berdnik, A. Llano, B. Mothe, C. Gálvez, S. Pérez-Álvarez, B. Oriol-Tordera, A. Olvera, S. Silva-Arrieta, M. Meulbroek, F. Pujol, J. Coll, J. Martinez-Picado, C. Ganoza, J. Sanchez, G. Gómez, T. Wyss-Coray, C. Brander
Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control
published pages: e00441-17, ISSN: 0022-538X, DOI: 10.1128/JVI.00441-17
Journal of Virology 91/16 2019-09-04
2016 Marit J. van Gils, Tom L. G. M. van den Kerkhof, Gabriel Ozorowski, Christopher A. Cottrell, Devin Sok, Matthias Pauthner, Jesper Pallesen, Natalia de Val, Anila Yasmeen, Steven W. de Taeye, Anna Schorcht, Stephanie Gumbs, Inez Johanna, Karen Saye-Francisco, Chi-Hui Liang, Elise Landais, Xiaoyan Nie, Laura K. Pritchard, Max Crispin, Garnett Kelsoe, Ian A. Wilson, Hanneke Schuitemaker, Per Johan Klasse, John P. Moore, Dennis R. Burton, Andrew B. Ward, Rogier W. Sanders
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability
published pages: 16199, ISSN: 2058-5276, DOI: 10.1038/nmicrobiol.2016.199
Nature Microbiology 2 2019-09-04
2017 Max Medina-Ramírez, Fernando Garces, Amelia Escolano, Patrick Skog, Steven W. de Taeye, Ivan Del Moral-Sanchez, Andrew T. McGuire, Anila Yasmeen, Anna-Janina Behrens, Gabriel Ozorowski, Tom L.G.M. van den Kerkhof, Natalia T. Freund, Pia Dosenovic, Yuanzi Hua, Alexander D. Gitlin, Albert Cupo, Patricia van der Woude, Michael Golabek, Kwinten Sliepen, Tanya Blane, Neeltje Kootstra, Mariëlle J. van Breemen, Laura K. Pritchard, Robyn L. Stanfield, Max Crispin, Andrew B. Ward, Leonidas Stamatatos, Per Johan Klasse, John P. Moore, David Nemazee, Michel C. Nussenzweig, Ian A. Wilson, Rogier W. Sanders
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo
published pages: 2573-2590, ISSN: 0022-1007, DOI: 10.1084/jem.20161160
The Journal of Experimental Medicine 214/9 2019-09-04
2017 Nicola Borthwick, Zhansong Lin, Tomohiro Akahoshi, Anuska Llano, Sandra Silva-Arrieta, Tina Ahmed, Lucy Dorrell, Christian Brander, Hayato Murakoshi, Masafumi Takiguchi, Tomáš Hanke
Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines
published pages: e0176418, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0176418
PLOS ONE 12/4 2019-09-04

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EAVI2020" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EAVI2020" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.2.)

LONGITOOLS (2020)

Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseases

Read More  

MindBot (2020)

Mental Health promotion of cobot Workers in Industry 4.0

Read More  

HEAP (2020)

Human Exposome Assessment Platform

Read More